• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, March 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Survey provides insight into Australian cataract surgery landscape

by Myles Hume
April 28, 2021
in Local, News, Ophthalmology, Research
Reading Time: 3 mins read
A A
cataract surgery collaborative care

Approximately 83,000 cataract operations are performed in Australia's public system each year. Image: flywish/Shutterstock.com.

Share on FacebookShare on Twitter

A new cataract surgery survey conducted through RANZCO has reaffirmed the gulf between the private and public systems, as well as a snapshot of surgeons’ perceptions of Snellen acuity and controversial simultaneous bilateral cataract procedures.

Leading Australian cataract surgeon Professor Gerard Sutton and Chris Hodge PhD, a clinical research coordinator at the Vision Eye Institute, recently distributed a short pilot questionnaire to gain a greater understanding of the local cataract surgery landscape, which they hope will inform further discussion on best practice.

Prof Gerard Sutton.

In an article published in RANZCO’s latest Eye2Eye magazine, they said 194 Fellows responded to their survey, with the majority (86.1%) performing the largest share of procedures within private practice.

According to the findings, private surgeons reported less waiting time for patients, with 96.9% indicating they could proceed to surgery within two months. This was compared with only 1.5% of patients in the public domain.

Further, 44.9% of public surgeons suggested that patients may wait between six to 12 months and 41.8% at least one year.

The use of Snellen acuity – and how much weight it should have in the prioritisation of cataract surgery – was also canvassed in the survey.

Noting it was an “inadequate tool”, Sutton and Hodge said that while 45.9% of respondents agreed Snellen acuity may be considered one part of an assessment to prioritise surgery lists, most respondents (80.4%) indicated 6/12 is not the most important determinant for surgical intervention.

“This finding appears to reflect global guidelines which do not place a hard limit on corrected visual acuity prior to undertaking surgery,” they wrote in the article.

“The number of available, validated quailty of vision questionnaires has increased in recent years, potentially providing more information on subjective complaints. Although only 8.3% suggested these are used routinely, 41.7% confirmed the use of their own non-standardised questions focussing on patient visual-based limitations in daily life.”

The duo also quizzed Australian ophthalmologists on their views about simultaneous bilateral cataract surgery (SBCS), which appears to have a limited local uptake.

Although it remains contentious, Sutton and Hodge point out it has become more prevalent in in Northern Europe with government compensation for day surgeries.

“Proponents may argue that the incidence of bilateral endophthalmitis is minimal, however it remains a primary concern for many,” they wrote.

“SBCS is undertaken in Australia, however our survey suggests it has minimal penetration at present with only 4.1% of respondents offering the service to patients. Furthermore, 95.4% of surgeons did not believe SBCS should be made mandatory as an alternate to routine practice of surgery on separate days. Of note, of those who complete SBCS, most surgeons (69%) only offered it to 5-10% of their patients, highlighting the current niche role in the patient/surgery discussion.”

The survey also covered the use of intracameral (I/C) antibiotics during cataract surgery. The latest issue of Eye2Eye can be found here.

More reading

Moderate wine consumption may keep cataracts at bay

Eliminating inefficiencies and never-events in cataract surgery

An IOL to change the cataract surgery paradigm?

Tags: Australiacataract surgeryMr Christopher HodgeProfessor GErard SuttonRANZCOSBCSsimultaneous bilateral cataract surgeySnellen acuitysurvey

Related Posts

Aussie Rules players in Darwin are being hit by mystery eye infections. Image: AlazySM/stock.adobe.com.

Aussie Rules players struck down by mystery eye infections

by Staff Writer
March 17, 2026

Eyecare professionals in the Northern Territory are scratching their heads over an outbreak of eye infection that has hit dozens...

Optos ultra-widefield imaging will be on show at events in Western Australia and NSW. Image: Prime Creative Media.

Optos technology on show in upcoming events

by Staff Writer
March 16, 2026

Optos is encouraging eyecare professionals serious about advancing patient care and staying ahead in eye health technology to visit its...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited